[go: up one dir, main page]

NO995030D0 - 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister - Google Patents

5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister

Info

Publication number
NO995030D0
NO995030D0 NO995030A NO995030A NO995030D0 NO 995030 D0 NO995030 D0 NO 995030D0 NO 995030 A NO995030 A NO 995030A NO 995030 A NO995030 A NO 995030A NO 995030 D0 NO995030 D0 NO 995030D0
Authority
NO
Norway
Prior art keywords
imidazolinylamino
alpha
compounds useful
adrenoceptor agonists
benzimidazole compounds
Prior art date
Application number
NO995030A
Other languages
English (en)
Other versions
NO995030L (no
Inventor
Thomas Lee Cupps
Sophie Eva Bogdan
Glen Edward Mieling
Nick Nikolaides
Raymond Todd Henry
Russell James Sheldon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO995030D0 publication Critical patent/NO995030D0/no
Publication of NO995030L publication Critical patent/NO995030L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO995030A 1997-04-15 1999-10-15 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister NO995030L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4231697P 1997-04-15 1997-04-15
PCT/IB1998/000540 WO1998046595A1 (en) 1997-04-15 1998-04-09 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists

Publications (2)

Publication Number Publication Date
NO995030D0 true NO995030D0 (no) 1999-10-15
NO995030L NO995030L (no) 1999-12-15

Family

ID=21921202

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995030A NO995030L (no) 1997-04-15 1999-10-15 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister

Country Status (12)

Country Link
EP (1) EP0975627A1 (no)
JP (1) JP2001519828A (no)
KR (1) KR20010006440A (no)
CN (1) CN1256691A (no)
AU (1) AU6514498A (no)
BR (1) BR9808904A (no)
CA (1) CA2285610A1 (no)
HU (1) HUP0002242A2 (no)
ID (1) ID24081A (no)
IL (1) IL132384A0 (no)
NO (1) NO995030L (no)
WO (1) WO1998046595A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0775134A4 (en) 1994-08-04 1997-08-13 Synaptic Pharma Corp NEW BENZIMIDAZOLE DERIVATIVES
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
US6486190B1 (en) * 1997-11-24 2002-11-26 The Procter & Gamble Company 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
US20040167194A1 (en) 2003-02-20 2004-08-26 Randall Jared Lynn Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN110540523B (zh) * 2018-07-05 2021-02-19 安徽圣诺贝化学科技有限公司 一种制备磺基取代苯并咪唑及其衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
EP0775134A4 (en) * 1994-08-04 1997-08-13 Synaptic Pharma Corp NEW BENZIMIDAZOLE DERIVATIVES

Also Published As

Publication number Publication date
IL132384A0 (en) 2001-03-19
ID24081A (id) 2000-07-06
BR9808904A (pt) 2005-02-22
JP2001519828A (ja) 2001-10-23
KR20010006440A (ko) 2001-01-26
EP0975627A1 (en) 2000-02-02
CA2285610A1 (en) 1998-10-22
NO995030L (no) 1999-12-15
AU6514498A (en) 1998-11-11
HUP0002242A2 (hu) 2001-04-28
CN1256691A (zh) 2000-06-14
WO1998046595A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
NO992470D0 (no) 2-amidazolinyl-amino-indolforbindelser anvendelige som &lt;alfa&gt;-2-adreno-reseptoragonister
DK1102762T3 (da) 2-substituerede-1-piperidylbenzimidazolforbindelser som ORL1-receptoragonister
NO20001141D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20001139L (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20001142D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20014824L (no) Bicykliske heteroaromatiske forbindelser anvendelige som LH- agonister
NO960393D0 (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
FI970328A0 (fi) Heterosykliset yhdisteet, jotka ovat käyttökelpoisia allosteerisinä effektoreina muskariinireseptoreissa
NO20030098L (no) &lt;Beta&gt;3 adrenergiske agonister
FI954738L (fi) Tetrasykliini yhdisteet dopamiiniagonisteina
NO992498L (no) Guanidinylheterocykelforbindelser anvendelige som &lt;alfa&gt;-2 adrenoceptoragonister
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO983594D0 (no) Heterosykliske tioetere som additiver for smöremidler
DK1228073T3 (da) Imidazolforbindelser som phosphodiesterase VII-inhibitorer
NO994106L (no) Oksazolidiner som 5-HT2A-antagonister
NO992500D0 (no) 2-imidazolinylaminobenzoksazolforbindelser anvendelige som &lt;alfa&gt;-2 adrenoceptoragonister
NO995030D0 (no) 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som &lt;alfa&gt;-2-adrenoseptoragonister
DK1011689T3 (da) Anvendelse af 9a-azalider som veterinære antimikrobielle midler
ID30056A (id) Agonis-agonis 5-htif
NO992503D0 (no) Guanidinylamino heterocykelforbindelser nyttige som &lt;alfa&gt;-2 adrenerge reseptoragonister
NO992502D0 (no) 2-Imidazolinylaminoindazolforbindelser nyttige som &lt;alfa&gt;-2 adrenerge reseptoragonister
NO20032582D0 (no) 1,2,4-oksadiazolderivater som HPPAR alfa agonister
ID18481A (id) 2-(3,5-difluorofenil)-3-(4-metilsulfonil)fenil)-2-siklopenten-1-on yang berguna sebagai inhibitor cox-2
NO20006214L (no) &lt;alfa&gt;-(1-piperaziny1)acetamidoarenkarboksylsyrederivater som antidiabetiske midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application